1.29  -0.12 (-8.51%)		08-28 16:00
Open: 1.4 High: 1.4 Volume: 18,866		Pre. Close: 1.41 Low: 1.29 Market Cap: 8(M)

Short term
Mid term
Targets	6-month :	1.78	1-year :	2.11
Resists	First :	1.52	Second :	1.8
Pivot price	1.3
Supports	First :	1.07	Second :	0.89
MAs	MA(5) :	1.25	MA(20) :	1.34
	MA(100) :	2.47	MA(250) :	3.76
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	59.5	D(3) :	46
RSI	RSI(14): 41.8
52-week	High :	9.47	Low :	1.07

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ XCUR ] has closed above bottom band by 44.9%. Bollinger Bands are 52.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	1.4 - 1.41	1.41 - 1.41
Low:	1.27 - 1.28	1.28 - 1.29
Close:	1.28 - 1.29	1.29 - 1.3

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.

Sat, 22 Aug 2026
Exicure (XCUR) Watch: Falls 11.54% to $1.15 in the Latest Session; Range View: Support at $1.09 and Resistance at $1.21 Frame the Range - Rounding Top - vinanet.vn

Fri, 14 Aug 2026
EXICURE, INC. Q2 2026: Revenue $0 Net income $(1.12M) — 10-Q Summary - TradingView

Mon, 03 Aug 2026
Exicure Announces Planned Issuance of Common Stock to Settle $1.0 Million Milestone Payment to GPCR Therapeutics - Quiver Quantitative

Wed, 29 Jul 2026
Exicure Inc (NASDAQ: XCUR) Share Price, XCUR Stock News, XCUR Share Price & Updates - kalkine.ca

Mon, 27 Jul 2026
Exicure Inc (XCUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Mon, 13 Jul 2026
How Exicure Inc. (XCUR) Affects Rotational Strategy Timing - Stock Traders Daily

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	7 (M)
Shares Float	3 (M)
Held by Insiders	41.4 (%)
Held by Institutions	2.2 (%)
Shares Short	107 (K)
Shares Short P.Month	7 (K)

EPS	-1.31
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.33
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-30.4 %
Return on Equity (ttm)	-168.4 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-1.09
Qtrly Earnings Growth	0 %
Operating Cash Flow	-7 (M)
Levered Free Cash Flow	-4 (M)

PE Ratio	-0.99
PEG Ratio	0
Price to Book value	3.9
Price to Sales	0
Price to Cash Flow	-1.27

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.